Finnish Health & Biotech Startup News

Finnish food startup, initially met with laughter by industry veterans, has expanded its product distribution to 2,000 stores with a +50% sales increase last year. The company aims to disrupt the traditional food sector.

Estonian biotech ÄIO partnered with skincare brand tilk! to launch a bio-fermented facial serum featuring ÄIO's RedOil. This marks ÄIO's first commercial product, available now via tilk!'s e-shop.

Finland has received a substantial €33 million in mining taxes, a significant boost to the national treasury. A noteworthy aspect of this revenue distribution is the concentration of benefits in six specific locations, with one small town receiving an impressive €5 million. This influx of funds is tied to the extraction of various minerals, including but not limited to nickel, zinc, and copper, all of which are vital components in modern technology and manufacturing. The specific town receiving the €5 million is located near a particularly active mining operation, highlighting the direct link between resource extraction and local economic gain. The amount of tax collected is linked to the volume and value of minerals extracted, as well as the prevailing tax rates for the mining industry.

Experts reveal that banned toxins from 32 years ago still lurk in unexpected places in Finnish homes. Many Finns are unaware of these dangerous locations and the risks they pose.

Sifted lists the top 20 equity deals in Europe. The list showcases the scale of investment flowing into various European startups and established companies.

Italian biotech firm NanoPhoria, developing inhalable therapies for heart disease, secured €83.5M to advance NP-MP1 to human trials. The therapy delivers biologics directly to target tissues.

Finland's Audicin, a neurotech company, secured $1.9M in funding from private investors, Petteri Lahtela, Virpi Tuomivaara and Business Finland. This brings their total funding to $3M to expand real-time nervous system regulation tools.

In 2025, Finnish tech saw €2.9B raised, with Nokia securing $1B from Nvidia. Early-stage activity remained strong across deeptech, AI, cleantech, and healthcare.

Arkadia Space, a Spanish space firm, secured €14.5M from the EIC (European Innovation Council) for its development of green propulsion technology using hydrogen peroxide. This funding package includes a €2.5M grant, €6M equity investment, and an additional €6M in private investment, showcasing a blended finance approach to supporting deep-tech innovation.

Epoch Biodesign, a London-based company developing enzymatic recycling technology, closed a $12M strategic funding round. Lululemon, KOMPAS VC, Happiness Capital, Extantia, and Leitmotif participated. March 2026. Total funding exceeds $50M.

Swedish Everdrone raised €3.3M led by Sciety to expand its autonomous drone service for emergency healthcare. Drones deliver defibrillators alongside ambulances in Sweden, France.

European tech companies secured over €504 million in funding across more than 55 deals last week, according to Tech.eu's weekly recap reported March 2026. The recap also noted 3 exits, M&A transactions, and related news.

Paris-based Parallel, developing AI agents for hospitals, secured a $20M Series A led by Index Ventures. Deployed across multiple hospitals, Parallel's AI focuses on automating administrative tasks.

Spanish tech companies raised €3.1B in 2025, highlighting growth and maturity. AI, deeptech, and frontier infrastructure led the way, alongside healthtech and enterprise software. Multiverse Computing raised the most at €256M.

Finnish deeptech startup Elea & Lili, a VTT spin-out, secured €2.5M in seed funding led by Lifeline Ventures to industrialize their cellulose-based superabsorbent material (CSA).

Alomana, an Italian startup focused on developing Alo - an AI operating layer (or platform) specifically designed for enterprises - has successfully closed a €4M seed funding round. The investment was primarily led by CDP Venture Capital, signaling strong confidence in Alomana's vision and technology. Alo is designed to personalize AI at scale, with the core objective of automating workflows across a diverse range of enterprise applications. This includes connecting disparate systems and data sources to enable intelligent automation of complex tasks.

Danish agritech Mycoverse raised €2.4M pre-seed led by Future Food Fund and HTGF, with Paulig's PINC participating. Funds will drive field trials of their fungal biocontrol for potato blight, a devastating disease that can wipe out entire potato crops. This investment highlights the growing interest in sustainable agricultural solutions and the potential of biotechnology to address critical challenges in food production. Mycoverse is positioning itself as a key player in this emerging field.

Oura, the Finnish health tech company, acquired Helsinki-based Doublepoint on March 5, 2026. Doublepoint specializes in AI-driven gesture recognition for controlling devices. The Doublepoint team joins Oura to advance AI-led experiences.

The United States has issued an official, and described as unusual, travel warning for those planning to visit Finland. The reason behind the warning was reported by Tekniikkatalous.

Austrian deeptech Fibionic raised €3M seed led by Redstone for its FFP technology that uses bionic principles for precise fiber placement in composites.

Mycoverse, an agritech spin-out from the Technical University of Denmark (DTU), has raised €2.4 million in pre-seed funding to develop fungal-based biological crop protection solutions, initially targeting potato late blight.

Milan-based Qura, an AI-powered full-stack health platform, has closed a €1.5 million pre-seed round to expand its integrated care pathway, combining blood testing, AI-driven analysis, and physician consultations.

Outpost Bio, focused on decoding interactions in human biology, raised a $3.5 million pre-seed round to develop its Lab-in-the-Loop platform. The platform combines automated experimentation with machine learning to create proprietary, human-derived functional data for pharmaceutical, food and consumer companies.

Noxon, a Munich-based medtech company, closed its seed funding round to advance its Muscle-Computer Interface. The wearable device combines continuous muscle diagnostics and neuromuscular electrical stimulation (NMES) for personalized rehabilitation and treatment of neuromuscular disorders.

YOU(th) Health Tech, a digital health company focused on preventive care, has secured $4.5 million in funding. The company uses smartphone sensor data and machine learning for health screenings, aiming to improve access to preventive tests.

Entteri Professional Software, a Finnish company providing information systems for private dental clinics, aims for international growth after winning awards for its AI-based dental X-ray analysis. They are offering the first version of their product free to customers.

CubaseBio, a Stockholm-based startup developing a 3D spatial transcriptomics platform, raised €5.9 million in funding from Voima Ventures, Nordic Science Investments, and others to commercialize its volumetric DNA microscopy technology.

CEOs of Swedish AI startups Legora (legaltech) and Tandem Health (healthtech) dismiss concerns about competition from OpenAI and Anthropic, highlighting the importance of industry-specific solutions.

Dublin-based Nocomed, a sustainability software company, has raised €650,000 in seed funding to expand its platform for measuring and reducing supply chain emissions in the healthcare sector.

Circle Health, a Berlin-based startup developing an integrated preventive care platform, Circle OS, has closed a €9 million seed round. The platform combines in-person diagnostics, AI-enabled clinical support, and consumer-facing digital health tools to offer personalized health programs.

Finland will receive its first amphibious bus that can travel on both land and water, with operations scheduled to begin this year.

Linda AI, a healthtech startup focused on automating front-desk operations for dental practices, has raised a €2.6 million pre-seed round to expand its AI-powered platform across Ireland and the UK.

Dutch startup QT Sense raised €4 million, including a €3 million seed round, to advance its Quantum Nuova platform for real-time cell analysis, enabling new approaches in spatial biology and drug discovery.

Lateral, a UK-based startup providing healthcare and financial wellness products for people over 60, raised £2.5 million in seed funding to roll out its Lateral Health Plan.

Biorce, a Barcelona-based health AI company, raised $52 million in a Series A round to expand its Aika AI platform for improving clinical trial design and execution globally.

Twogee Biotech, a Munich-based biotechnology start-up, has completed a €2.2 million seed round to develop enzyme solutions for converting biomass into sustainable raw materials. The company's technology aims to support industrial partners in creating circular, low-CO₂ value chains.

Avenue Biosciences is a transatlantic biotech company with a strong scientific background, whose artificial intelligence platform enhances the development and production of biological protein drugs.

Nordic Bioproducts Group, an Espoo-based biomaterials deeptech company originating from Aalto University, has received a strategic minority investment from Japan’s Oji Holdings Corporation. The investment will help scale its AaltoCell™ cellulose platform, focusing on industrial development and market readiness.

Sweden's Sigrid Therapeutics has partnered with a multinational consumer health player to develop and commercialize its SiPore® technology in oral care. The deal includes upfront, milestone payments, and royalties, allowing Sigrid to expand its platform without diverting resources from its metabolic health products.

Cancilico, a Dresden-based AI diagnostics startup specializing in blood cancer, secured €2.5 million in Seed funding to further develop its MyeloAID software for analyzing bone marrow samples with AI, aiming to improve blood cancer diagnostics.

Touchwaves, a Dutch deeptech startup, raised €1.5 million in pre-seed funding to develop wearable haptics technologies for human performance and situational awareness, focusing initially on military aviation. The technology also has potential applications in elite sports, ground operations, and healthcare.

Ahead Health, a Zurich-based startup, raised $6 million to develop an AI-powered platform for preventive check-ups, including MRI scans and advanced blood tests. The platform aims to provide personalized, actionable insights for early detection of conditions like cancer and cardiovascular disease.

Verna, a UK-based startup, raised $4 million to support its nature recovery software. The platform helps organizations translate nature-related commitments into practical, measurable results by integrating existing data sources to track progress and improve biodiversity outcomes.

Swiss biotech startup FluoSphera raised €1.23M to expand its human-relevant preclinical platform, which aims to predict drug responses more accurately and reduce reliance on animal models.

Elomatic, a design and consulting company, provides solutions for industries crucial to security of supply and overall safety, including the pharmaceutical and maritime sectors, focusing on dual-use technologies.

ViCentra, a Dutch medical device company that commercializes the Kaleido insulin patch pump system, has raised an additional $13 million as part of its Series D financing to expand manufacturing, strengthen commercial operations, and accelerate preparations for bringing its next-generation Kaleido system to the U.S. market.

Bactolife, a Copenhagen-based company developing Binding Protein technology for gut health, raised over €30 million in a Series B round to fund large-scale human studies, scale manufacturing, and support global market entry, with the first product launch planned in the US in 2026.

Stockholm-based Sigrid has raised $5 million to expand its metabolic health platform in the U.S. and develop new verticals. The company's focus is on non-systemic solutions for blood sugar and weight management.

Helsinki-based MultivisionDx raised €1 million in a pre-seed round led by Antler, with participation from Helsinki University Funds and others. The funding will accelerate the development of their spatial biology platform for personalized cancer care.

Oxford-based A&B Smart Materials secured £1.5M in pre-seed funding to develop fully biodegradable alternatives to fossil-based superabsorbent polymers for hygiene and agricultural applications, aiming to reduce microplastic pollution.

Mindoo, a European platform for AI-powered healthcare workflows, raised €5 million in seed funding to develop its AI agents and expand its platform across hospitals in Europe.

Lucis, a French startup, secured $8.5 million in seed funding to expand its preventive health testing platform across Europe, offering users a structured view of biomarkers and personalized action plans.

The article discusses a large-scale biomedical experiment conducted in Finland in the 1970s, highlighting its historical significance and unique nature.

The article discusses the potential of the European bioeconomy and how the Finnish forest industry is positioning itself in this emerging market.

Helsinki-based Gosta Labs, founded by the team behind Kaiku Health, has raised €7.5 million in seed funding to expand its AI-powered operating system for oncology globally. The system aims to streamline cancer care by structuring patient data and automating clinical documentation.

Oslo-based Noteless, an AI company focused on improving how doctors document patient consultations, has raised €3.5 million in seed funding to expand across Europe. Their AI-powered tool automatically generates medical notes in real time during consultations.

Planet Smart, a London-based deep tech startup, raised $1 million in pre-seed funding to launch PlanetSorb, a biodegradable superabsorbent polymer (SAP) designed to replace fossil-based plastics in nappies and other hygiene products. The company plans to scale up production and conduct pilot trials.

InvenireX, a Newcastle-based biotech startup, secured £2 million in Seed funding to commercialize its DNA nanotechnology platform that detects disease at the earliest biological stages. The platform uses DNA nanostructures and AI to identify disease markers with greater sensitivity and speed than current methods.

Sofinnova Partners, a life sciences venture capital firm, has closed its latest fund, Sofinnova Capital XI, at €650 million. The fund will support early-stage biotech and medtech ventures across Europe and North America.

A Finnish startup is building the world's first biorefinery of its kind in Kokkola, focusing on extracting chemicals from seaweed. This project represents a significant step in sustainable chemical production.

European VC saw €8.3B invested in October, dominated by healthtech, with 14 nine-figure raises, including Nvidia-Nokia’s €1B AI telecom partnership and Oura’s €900M boost.

Balnord, an early-stage investor focused on the Baltic Sea region, has exceeded its €70 million fund target and is on track for a final close of €100 million by mid-2026. The fund targets companies advancing Europe’s technological reindustrialisation, focusing on space, healthcare, and industrial resilience.

A report by Tesi indicates that Finland has the potential to build growth through new industries, particularly in hydrogen, bioproducts, metals, minerals, and data centers, leveraging clean energy and strong infrastructure.

Human Health, a London-based precision health platform, has secured €4.7 million in seed funding. The platform combines patient-reported data with AI to create personalized healthcare insights, with the goal of extending access to tools typically reserved for clinicians.

Paris-based Primaa, an AI software developer for cancer diagnostics, has raised €7 million. The funding will support European deployment, feature development, and international expansion, particularly in the United States with planned FDA certification activities.

EPFL spin-off MoleSense has received €156,000 from Venture Kick to develop molecular wearables for continuous, non-invasive monitoring of biochemical markers in high-risk pregnancies, aiming to provide real-time insights for early diagnosis and targeted interventions.

roclub, a teleoperation platform for medical technology, secured $11.7 million in Series A funding. The platform allows remote access and control of medtech equipment, addressing staffing shortages and improving access to healthcare.

London-based Orbiri raised £320,000 for its community-powered platform that helps children, parents, and schools align on shared digital limits, aiming to create healthier technology use habits.

Meta-Flux, a Dublin-based biotech startup, raised €1.8M in Seed funding to expand its AI-driven decision-support platform for preclinical drug development, helping scientists identify promising therapeutic pathways and make faster decisions.

Finnish healthtech companies are quietly disrupting the global healthcare landscape with innovative solutions, addressing challenges and improving care delivery worldwide.

Datamonk, a Dutch agentic AI-powered platform, has raised €1.6 million in pre-seed funding to automate and improve the migration of medical imaging data for hospitals. The platform uses AI agents to clean, standardize, and validate data during transfer, significantly reducing manual effort and accelerating the process.

The Medical Travel Company (TMTC), a UK and India-based startup, has raised €3.8 million to expand its full-stack medical travel platform. TMTC offers UK patients access to affordable medical treatments in India, including end-to-end logistics, UK doctor involvement, and post-surgery insurance.

Natus Medical, a U.S.-based neurodiagnostics company, has fully acquired Holberg EEG, a Norwegian company specializing in AI-powered EEG interpretation. The acquisition will integrate Holberg's autoSCORE AI model into Natus's neurodiagnostic portfolio, aiming to improve brain health solutions worldwide.

A new type of paper has been developed in Finland that is fully biodegradable, waterproof, and can be manufactured cheaply using standard cardboard machines.

Berlin-based praxipal, developing an AI receptionist for healthcare front desks, has secured $6.7 million in seed funding to expand beyond orthodontics, further develop capabilities, and broaden rollouts.

Outlast Fund, a Riga and Stockholm-based VC, has closed a €21M fund to invest in pre-seed and seed-stage startups in the Baltics and Nordics, focusing on B2B SaaS, fintech, and digital health.

Berlin-based OpenHealth Technologies has raised $3 million in seed funding to expand its AI-driven medical platform across Europe. The company aims to modernize lab data infrastructure, transforming raw results into harmonized, AI-ready datasets.

Espoo-based Agate Sensors, an Aalto University spin-out developing smart sensors for material analysis, has raised €5.6 million in seed funding and grants. The funding will help commercialize its chip-scale spectral sensing technology for various applications, including healthcare, defense, and environmental monitoring.

A Finnish study suggests that AI has the potential to assist in education and healthcare by analyzing and interpreting human behavior.

Phasecraft, a quantum algorithms company, has raised $34 million in Series B funding to accelerate the development of its algorithms and transition quantum computing from theoretical to practical applications. The algorithms are hardware-agnostic and are being used to optimize material science, biological research and energy networks.

Journalia, a Norwegian healthtech startup, secured $1 million in funding to expand its AI-powered clinical documentation platform that automates note generation for healthcare providers, freeing up their time for patient care.

Interhuman AI, a Copenhagen-based startup developing a social intelligence layer for AI, raised €2 million in a pre-seed round led by PSV Tech. The funding will be used to expand the team and advance the company’s models and API, targeting training, healthcare, and customer interaction.

The European Commission's proposal for a competitiveness fund for 2028-2034 offers opportunities for Finnish companies, with significant investments in security, innovation, digital technologies, low carbon and bioeconomy, totaling over 400 billion, particularly in security and digitalization.